ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: pediatric

Clinical Remission Should Be Target of JIA Treatment: Task Force

Reuters Staff  |  April 27, 2018

NEW YORK (Reuters Health)—An international task force says patients with juvenile idiopathic arthritis (JIA) should be treated to a target of clinical remission, among other new recommendations. “The Task Force is convinced that transferring (the recommendations) into clinical practice will significantly improve the outcomes in patients with JIA,” Dr. Angelo Ravelli of the Istituto G….

Filed under:ConditionsPractice SupportProfessional Topics Tagged with:Angelo Ravelliclinical remissioninternational task forcejuvenile idiopathic arthritis (JIA)

Genetics Suggest Adult & Child Arthritis Aren’t So Different

Kurt Ullman  |  April 26, 2018

There has long been a wall separating adult rheumatologists from pediatric rheumatologists. A recent review article published in the January edition of Arthritis & Rheumatology (A&R) suggests that genetics, rather than age, may be a better way to categorize forms of primary inflammatory arthritis across the lifespan.1 “Pediatric and adult rheumatologists don’t generally interact that…

Filed under:Conditions Tagged with:adult arthritisArthritisJuvenile arthritispediatric arthritis

Social Media Connects, Informs Rheumatologists

Linda Childers  |  April 26, 2018

When Paul Sufka, MD, a rheumatologist with HealthPartners Medical Group and Regions Hospital in St. Paul, Minn., wants to connect with his colleagues or keep abreast of the latest rheumatology journal articles, he turns to Twitter. Dr. Sufka is one of many rheumatologists who have found effective ways to incorporate social media into their medical…

Filed under:Education & Training Tagged with:communicationSocial MediaTwitter

Septic or Lyme Hip Arthritis? Rapid Lyme Diagnostics Could Avoid Unnecessary Treatment

Reuters Staff  |  April 26, 2018

NEW YORK (Reuters Health)—In Lyme-endemic areas, synovial fluid white blood cell (WBC) count isn’t very helpful in distinguishing septic from Lyme arthritis of the hip, a new study suggests. Use of newer-generation Lyme disease diagnostics are necessary to avoid the “under- and overdiagnosis of Lyme arthritis at the time that initial management decisions must be…

Filed under:Conditions Tagged with:Lyme arthritisLyme Diseaseseptic arthritissynovial fluid

Sharing Knowledge to Support Care: A Conversation with ACR Communications & Marketing Committee Member Suleman Bhana, MD, FACR

Carina Stanton  |  April 20, 2018

Whether he is teaching rheumatologists how to leverage technology tools in their practice or working with the ACR’s Communications and Marketing Committee (CMC) to connect members with practice knowledge and support, Suleman Bhana, MD, FACR, a rheumatologist with Crystal Run Healthcare in Middletown, N.Y., is focused on connecting with his colleagues to improve patient care….

Filed under:Profiles Tagged with:ACR Communications and Marketing CommitteeSuleman Bhana

The ACR Updates Biosimilar Position Statement

Keri Losavio  |  April 4, 2018

In March, the ACR released a white paper designed primarily to help rheumatologists and rheumatology health professionals gain an understanding of biosimilars.1 This research-based education piece examines the scientific, economic and prescribing issues related to the use of biosimilars. Now, the ACR has released an update to its official position statement on the use of…

Filed under:Biologics/DMARDsDrug Updates Tagged with:position statement

Ethics Forum: What to Do When an Autoimmune Patient Needs a Transplant?

W. Blaine Lapin, MD, Jennifer L. Rammel, MD, MPH, & Andrea A. Ramirez, MD, MEd  |  March 19, 2018

Despite our best efforts and modern interventions, we still have patients in the intensive care unit with organ failure. Although renal failure can be mitigated by dialysis, patients with cardiac or respiratory failure secondary to active autoimmune disease raise difficult clinical and ethical issues. Two recent cases, both with organ failure, led us to examine…

Filed under:ConditionsEthics Tagged with:transplantation

Updates on Managing Lupus Complications

Susan Bernstein  |  March 17, 2018

SAN DIEGO—To manage patients with systemic lupus erythematous (SLE), rheuma­tologists must be aware of potentially serious complications affecting many organ systems. On Nov. 7 at the 2017 ACR/ARHP Annual Meeting, two experts offered insights on cardiovascular and hematological complications of lupus. Myocardial Disease in Lupus Lupus patients are at increased risk for heart-related complications, especially…

Filed under:Meeting ReportsSystemic Lupus Erythematosus Tagged with:ACR/ARHP Annual MeetinganemiaCoombshemolysisLupusmyocardial inflammationSLEsplenectomy

2 Fellowship Directors Debate ACGME Milestones Eval System

Larry Beresford  |  March 17, 2018

SAN DIEGO—The Next Accreditation System, the newest process for evaluating medical residency and fellowship programs and their participants, including future rheumatologists, was implemented in 2014 by the Accreditation Council for Graduate Medical Education (ACGME). The system introduced specialty-specific milestones designed to reflect significant points in professional development. Milestones are defined by ACGME as a rubric…

Filed under:Education & TrainingMeeting Reports Tagged with:ACGMEACR/ARHP Annual MeetingGMEmilestones

The Latest Autoinflammatory Discoveries & Tips

Thomas R. Collins  |  March 17, 2018

SAN DIEGO—Since the identification of the autoinflammatory disease, familial Mediter­ranean fever (FMF), researchers have identified an alphabet soup of other auto­inflammatory diseases with genetic underpinnings, from PAPA (pyogenic arthritis with pyoderma gangrenosum and acne) to NIAID (NLRP1-associated autoinflammation with arthritis and dyskeratosis) to TRAPS (TNF receptor-associated periodic syndrome). The torrent of discoveries, brought about largely…

Filed under:ConditionsMeeting ReportsOther Rheumatic Conditions Tagged with:ACR/ARHP Annual Meetingadult Still's Diseaseanakinraautoinflammatory disease

  • « Previous Page
  • 1
  • …
  • 63
  • 64
  • 65
  • 66
  • 67
  • …
  • 112
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences